- Home
- WRLD vs OVID Comparison
WRLD vs OVID Comparison
Compare WRLD & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WRLD | OVID |
|---|---|---|
| Founded | 1962 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 646.0M | 522.6M |
| IPO Year | 1994 | 2017 |
Fundamental Metrics
Financial Performance| Metric | WRLD | OVID |
|---|---|---|
| Price | $158.01 | $2.44 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $4.60 |
| AVG Volume (30 Days) | 153.9K | ★ 1.8M |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.90 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $564,841,465.00 | $7,252,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.51 | $19.34 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1181.27 |
| 52 Week Low | $110.00 | $0.27 |
| 52 Week High | $185.48 | $3.11 |
Technical Indicators
Market Signals| Indicator | WRLD | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 63.42 | 39.87 |
| Support Level | $124.56 | $1.23 |
| Resistance Level | $163.80 | $2.72 |
| Average True Range (ATR) | 6.23 | 0.17 |
| MACD | 0.63 | -0.06 |
| Stochastic Oscillator | 97.26 | 15.15 |
Price Performance
Historical ComparisonAbout WRLD World Acceptance Corporation
World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals. The Company operates 1,024 branches in Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Texas, Tennessee, Utah, and Wisconsin.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.